Concurrent chemoradiotherapy for oropharyngeal carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 1, 2001, Pages 71-76

  Kokubo, Masaki ^a   Nagata, Yasushi ^a   Nishimura, Yasumasa ^b   Kimura, Hiroyuki ^a   Shoji, Kazuhiko ^a   Asato, Ryo ^a   Sasai, Keisuke ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Cisplatin; Concurrent chemoradiotherapy; Oropharyngeal carcinoma; Radiation therapy

Indexed keywords

CARBOPLATIN; CISPLATIN; PEPLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NECK DISSECTION; OROPHARYNX CARCINOMA; RADIATION DOSE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0035116206     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200102000-00013     Document Type: Article

References (33)

1. Evolution of the radiation therapy Oncology Group clinical trials for head and neck cancer
2. Oropharyngeal carcinoma treated with radiotherapy: A 30-year experience
3. Organ-function preservation in advanced oropharynx cancer: Results with induction chemotherapy and radiation
4. Performance status after treatment for squamous cell cancer of the base of tongue - A comparison of primary radiation therapy versus primary surgery
5. Speech and survival: Tradeoffs between quality and quantity of life in laryngeal cancer
6. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial
7. Combined treatment of radiation and cisdiamminedichloroplatinum (II): A review of experimental and clinical data
8. Platinum complexes as radiosensitizers of hypoxic mammalian cells
9. Biologic rationale of combined radiotherapy and chemotherapy
10. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
11. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma
12. Sequential chemotherapy and radiotherapy for organ preservation in advanced resectable nonlaryngeal head and neck cancer
13. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer
14. Concurrent cisplatinum and radiation with or without surgery for advanced head and neck cancer
15. Overview
16. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group
17. Head and neck cancer
18. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
19. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin-C and 5-fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma
20. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
21. Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: A phase III study
22. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials
23. Phase I study of concomitant chemo-radiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck
24. Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice
25. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
26. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
27. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
28. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
29. Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: Clinical and pharmacological data of a French multicenter phase II study
30. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
31. Hyperfractionated radiation therapy with or without concurrent low-dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
32. Analysis of the results of irradiation in the treatment of squamous cell carcinomas of the pharyngeal walls
33. Clinical radiobiology of squamous cell carcinoma of the oropharynx